Presentation TCT 2019 Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend? Presenter: Jean Fajadet September 27, 2019
Presentation TCT 2019 Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated? Presenter: Davide Capodanno September 27, 2019
Presentation TCT 2019 Does Stent Design Make a Difference in Treating LM Bifurcation Lesions? Presenter: Fazila Malik September 27, 2019
Presentation TCT 2019 Potential Study Designs to Address the Mortality Safety Signal Presenter: Laura Mauri September 26, 2019
Presentation TCT 2019 Study Design Considerations for HBR Patients in Japan Presenter: Yasuko Nakamura September 26, 2019
Presentation TCT 2019 Study Design Considerations for HBR Patients and DES Platforms: FDA View Presenter: Adrian Magee September 26, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
Presentation TCT 2019 Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices Presenter: Brian Whisenant September 26, 2019
Presentation TCT 2019 FDA Pivotal Clinical Trial Design and Beyond Presenter: Ori Ben-Yehuda September 26, 2019
Presentation TCT 2019 Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population Presenter: Sandeep Basavarajaiah September 26, 2019
Presentation TCT 2019 A Personal Perspective: Why I Choose Orsiro in STEMI Presenter: Juan Fernando Iglesias September 26, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019
Presentation TCT 2019 Real-World Data From EASTBOURNE to TRANSFORM Trials Presenter: Bernardo Cortese September 26, 2019
Presentation TCT 2019 First Experience With FDA-Approved Orsiro in the USA Presenter: Farouc Jaffer September 26, 2019
Presentation TCT 2019 First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results Presenter: Alexandre Abizaid September 26, 2019
Presentation TCT 2019 Why SEB Should Be Safer: Insights From Preclinical Study Presenter: Aloke Finn September 26, 2019
Presentation TCT 2019 MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent Presenter: Ken Kozuma September 26, 2019